Open Access
| Issue |
BIO Web Conf.
Volume 233, 2026
9th International Conference on Advances in Biosciences and Biotechnology: Emerging Innovations in Biomedical and Bioengineering Sciences (ICABB 2026)
|
|
|---|---|---|
| Article Number | 01013 | |
| Number of page(s) | 11 | |
| Section | Biomedical and Health Innovations | |
| DOI | https://doi.org/10.1051/bioconf/202623301013 | |
| Published online | 23 April 2026 | |
- Parakh S, Ernst M, Poh AR. Multicellular effects of STAT3 in non-small cell lung cancer: Mechanistic insights and therapeutic opportunities. Cancers (Basel) 2021;13:6228. https://doi.org/10.3390/cancers13246228. [Google Scholar]
- Papavassiliou KA, Anagnostopoulos N, Papavassiliou AG. Lung cancer through transcription factors. Int J Mol Sci 2023;24:9461. https://doi.org/10.3390/ijms24119461. [Google Scholar]
- Ozen M, Lopez CF. Data-driven structural analysis of Small Cell Lung Cancer transcription factor network suggests potential subtype regulators and transition pathways. bioRxiv.org 2023. https://doi.org/10.1101/2023.04.01.535226. [Google Scholar]
- Mitra P. Targeting transcription factors in cancer drug discovery. Explor Target Antitumor Ther 2020;1:401–12. https://doi.org/10.37349/etat.2020.00025. [Google Scholar]
- Zhang L, Ludden CM, Cullen AJ, Tew KD, Branco de Barros AL, Townsend DM. Nuclear factor kappa B expression in non-small cell lung cancer. Biomed Pharmacother 2023;167:115459. https://doi.org/10.1016/j.biopha.2023.115459. [Google Scholar]
- Tan X, Kroneberg M, Sun F, Diaz KA, Flora A, Carey MF. AP-1 promotes oncogenic transcription in lung cancer cells by bridging promoter-enhancer interactions. Cancer Gene Ther 2025:1-13. https://doi.org/10.1038/s41417-025-00974-w. [Google Scholar]
- Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev 2010;36:151–6. https://doi.org/10.1016/j.ctrv.2009.11.006. [Google Scholar]
- Mollaoglu G, Jones A, Wait SJ, Mukhopadhyay A, Jeong S, Arya R, et al. The lineage defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment. Immunity 2018;49:764–779.e9. https://doi.org/10.1016/j.immuni.2018.09.020. [Google Scholar]
- Zhuang JJ, Liu Q, Wu DL, Tie L. Current strategies and progress for targeting the “undruggable” transcription factors. Acta Pharmacol Sin. 2022 Oct;43(10):2474–2481. doi: 10.1038/s41401-021-00852-9. Epub 2022 Feb 7. PMID: 35132191; PMCID: PMC9525275. [Google Scholar]
- Tang C, Hartley GP, Couillault C, Yuan Y, Lin H, Nicholas C, et al. Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer. BMJ Oncol 2024;3:e000133. https://doi.org/10.1136/bmjonc-2023-000133. [Google Scholar]
- Li D, Yang W, Zhang J, Yang JY, Guan R, Yang MQ. Transcription Factor and lncRNA Regulatory Networks Identify Key Elements in Lung Adenocarcinoma. Genes 2018;9(5):251. https://doi.org/10.3390/genes9050251. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.